Publication:
Retrospective and Multicenter Analysis of Efficacy and Safety of Ruxolitinib in 176 Turkish Patients with Myelofibrosis: Updated Data

dc.contributor.authorSoyer, N.
dc.contributor.authorAli, R.
dc.contributor.authorTurgut, M.
dc.contributor.authorHaznedaroglu, I.
dc.contributor.authorYilmaz, F.
dc.contributor.authorAydogdu, I.
dc.contributor.authorInce, I.
dc.contributor.authorIDKarakus, Volkan/0000-0001-9178-2850
dc.contributor.authorIDHaznedaroglu, Ibrahim C./0000-0001-8028-9462
dc.date.accessioned2020-06-21T13:06:50Z
dc.date.available2020-06-21T13:06:50Z
dc.date.issued2018
dc.departmentOMÜen_US
dc.department-temp[Soyer, N.] Ege Univ, Dept Hematol, Fac Med, Izmir, Turkey -- [Ali, R.] Uludag Univ, Dept Hematol, Fac Med, Bursa, Turkey -- [Turgut, M.] Ondokuz Mayis Univ, Dept Hematol, Fac Med, Samsun, Turkey -- [Haznedaroglu, I.] Hacettepe Univ, Dept Hematol, Fac Med, Ankara, Turkey -- [Yilmaz, F.] Ataturk Training & Res Hosp, Dept Hematol, Izmir, Turkey -- [Aydogdu, I.] Celal Bayar Univ, Dept Hematol, Fac Med, Manisa, Turkey -- [Pir, A.] Karadeniz Tech Univ, Dept Hematol, Fac Med, Trabzon, Turkeyen_US
dc.description9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKEYen_US
dc.description.abstracten_US
dc.identifier.endpageS46en_US
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.startpageS46en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11417
dc.identifier.volume73en_US
dc.identifier.wosWOS:000447176600107
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.journalLeukemia Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRetrospective and Multicenter Analysis of Efficacy and Safety of Ruxolitinib in 176 Turkish Patients with Myelofibrosis: Updated Dataen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files